eHEALTH Bureau
Scientists from Allahabad University have collaborated with Institute of Molecular Medicine, University of Lubeck, Germany to develop a new drug to combat AIDS. The research would be undertaken by the renowned scientist from the University and their counterparts from AU.
The research would be initiated by professor Bechan Sharma, department of biochemistry, AU and prof Tobias Restle, Institute of Molecular Medicine, University of Lubeck, Germany. The joint endeavour would explore the molecular intricacies involved in the HIV-1 RT, the key enzyme responsible for generation of mutations in HIV-1 genome. The outcome of the research would enable the development of safe and cost effective anti HIV-1 drugs.
According to figures released by the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization (WHO). India shares 10 per cent of global HIV burden and 65 per cent of South-East Asian population. It is reported that 5.2 million HIV infections exist in India. The national HIV prence was between 0.4 and 1.3 percent HIV-1 in 2003.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
